Cellnovo Group (“Cellnovo” CLNV:EN Paris), a medical technology company marketing the first mobile, connected, all-in-one diabetes management system, today announces the signature of several distribution agreements covering six new markets to make its mobile diabetes management system available internationally.
Cellnovo has signed an agreement with Novalab Ibérica SAU for the distribution of the Cellnovo System in Spain. Novalab Iberica, a subsidiary of Air Liquide Healthcare, is a leading medical devices distributor offering solutions for diabetes patients. The process for registration to allow commercialisation in Spain is underway with the national authorities, and the Company anticipates its first commercial sales by the end of 2017. Cellnovo will be the first micro-pump available in Spain.